-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, T1Ti1T+T+3n1eeAZnPe0SQKN5T04PphbendYvNXHKbNcrUjawMwEY9wmid2PSzCP HGtuhSCmr/2eOZuIIili/Q== 0000912057-01-509495.txt : 20010421 0000912057-01-509495.hdr.sgml : 20010421 ACCESSION NUMBER: 0000912057-01-509495 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010419 GROUP MEMBERS: DANIEL A. DECKER GROUP MEMBERS: DONALD J. MCNAMARA GROUP MEMBERS: EXPLORER HOLDINGS GENPAR, LLC GROUP MEMBERS: EXPLORER HOLDINGS LP GROUP MEMBERS: HAMPSTEAD INVESTMENT PARTNERS III, L.P. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-43542 FILM NUMBER: 1606161 BUSINESS ADDRESS: STREET 1: 900 VICTORS WAY STREET 2: STE 350 CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: 7348870200 MAIL ADDRESS: STREET 1: 900 VICTORS WAY STREET 2: STE 350 CITY: ANN ARBOR STATE: MI ZIP: 48108 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: EXPLORER HOLDINGS LP CENTRAL INDEX KEY: 0001120288 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 752886947 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: OMEGA HEALTHCARE INVESTORS INC STREET 2: 900 VICTORS WAY SUITE 350 CITY: ANN ARBOR STATE: MI ZIP: 734870200 MAIL ADDRESS: STREET 1: 4200 TEXAS COMMERCE TOWER WEST STREET 2: 2200 ROSS AVENUE CITY: DALLAS STATE: TX ZIP: 75201 SC 13D/A 1 a2045306zsc13da.txt SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1) Omega Healthcare Investors, Inc. ------------------------------------------------------------------------ (Name of Issuer) Common Stock, par value $0.10 per share ------------------------------------------------------------------------ (Title of Class of Securities) 681936100 ------------------------------------------------------ (CUSIP Number) Thomas W. Bark, Esq. Jones, Day, Reavis & Pogue 599 Lexington Avenue New York, New York 10022 (212) 326-7815 ------------------------------------------------------------------------ (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 30, 2001 --------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the reporting person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box /_/. NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent. CUSIP NO. 681936100 13D Page 2 of 14 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Explorer Holdings, L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) /_/ - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) /_/ - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY None OWNED BY -------------------------------------------------------------- EACH REPORTING 8 SHARED VOTING POWER PERSON WITH 16,774,720** -------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER None -------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 16,774,720** - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 16,774,720** - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES/_/* - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 45.6% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! **This amount includes (i) 1,000,000 shares of Series C Convertible Preferred stock previously reported by the Reporting Person, which are convertible into 16,000,000 shares of Omega's common stock and (ii) 48,420 shares of Series C Convertible Preferred Stock acquired by the Reporting Person on March 30, 2001, which are convertible into 774,720 shares of Omega's common stock. CUSIP NO. 681936100 13D Page 3 of 14 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Explorer Holdings GenPar, LLC - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) /_/ - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) /_/ - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY None OWNED BY -------------------------------------------------------------- EACH REPORTING 8 SHARED VOTING POWER PERSON WITH 16,774,720** -------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER None -------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 16,774,720** - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 16,774,720** - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES/_/* - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 45.6% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* 00 - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! **This amount includes (i) 1,000,000 shares of Series C Convertible Preferred stock previously reported by the Reporting Person, which are convertible into 16,000,000 shares of Omega's common stock and (ii) 48,420 shares of Series C Convertible Preferred Stock acquired by the Reporting Person on March 30, 2001, which are convertible into 774,720 shares of Omega's common stock. CUSIP NO. 681936100 13D Page 4 of 14 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Hampstead Investment Partners III, L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) /_/ - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) /_/ - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Texas - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY None OWNED BY ------------------------------------------------------------- EACH REPORTING 8 SHARED VOTING POWER PERSON WITH 16,774,720** ------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER None ------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 16,774,720** - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 16,774,720** - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES/_/* - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 45.6% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! **This amount includes (i) 1,000,000 shares of Series C Convertible Preferred stock previously reported by the Reporting Person, which are convertible into 16,000,000 shares of Omega's common stock and (ii) 48,420 shares of Series C Convertible Preferred Stock acquired by the Reporting Person on March 30, 2001, which are convertible into 774,720 shares of Omega's common stock. CUSIP NO. 681936100 13D Page 5 of 14 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Donald J. McNamara - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) /_/ - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) /_/ - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY None OWNED BY ------------------------------------------------------------- EACH REPORTING 8 SHARED VOTING POWER PERSON WITH 16,774,720** ------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER None ------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 16,774,720** - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 16,774,720** - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES/_/* - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 45.6% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! **This amount includes (i) 1,000,000 shares of Series C Convertible Preferred stock previously reported by the Reporting Person, which are convertible into 16,000,000 shares of Omega's common stock and (ii) 48,420 shares of Series C Convertible Preferred Stock acquired by the Reporting Person on March 30, 2001, which are convertible into 774,720 shares of Omega's common stock. CUSIP NO. 681936100 13D Page 6 of 14 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Daniel A. Decker - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) /_/ - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) /_/ - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY None OWNED BY ------------------------------------------------------------- EACH REPORTING 8 SHARED VOTING POWER PERSON WITH 16,774,720** ------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER None ------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 16,774,720** - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 16,774,720** - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES/_/* - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 45.6% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! **This amount includes (i) 1,000,000 shares of Series C Convertible Preferred stock previously reported by the Reporting Person, which are convertible into 16,000,000 shares of Omega's common stock and (ii) 48,420 shares of Series C Convertible Preferred Stock acquired by the Reporting Person on March 30, 2001, which are convertible into 774,720 shares of Omega's common stock. This amendment amends and supplements the information set forth in the Statement on Schedule 13D filed on May 25, 2000 by (i) Explorer Holdings, L.P., a Delaware limited partnership ("HOLDINGS"), (ii) Explorer Holdings GenPar, LLC, a Delaware limited liability company and the general partner of Holdings ("GENERAL PARTNER"), (iii) Hampstead Investment Partners III, L.P., a Delaware limited partnership ("PARENT"), (iv) Donald J. McNamara, and (v) Daniel A. Decker, relating to securities of Omega Healthcare Investors, Inc., a Maryland corporation (the "COMPANY"). Holdings, General Partner, Parent and Messrs. McNamara and Decker are collectively referred to herein as Reporting Persons. ITEM 1. SECURITY AND ISSUER. This amendment relates to the Series C Convertible Preferred Stock, par value $1.00 per share (the "PREFERRED STOCK"), of the Company. ITEM 5. INTEREST IN SECURITY OF THE ISSUER. Item 5 is hereby amended and supplemented by adding thereto the following: (a) Each of the Reporting Persons beneficially owns 16,774,720 Shares, consisting of (i) 1,000,000 shares of Preferred Stock previously reported, which are convertible into 16,000,000 shares of common stock of the Company and (ii) 48,420 shares of Preferred Stock acquired by the Reporting Persons on March 30, 2001, which are convertible into 774,720 shares of common stock of the Company. (c) Holdings received 46,666 shares of Preferred Stock on March 30, 2001 as "paid-in-kind" dividends on the Preferred Stock for the period from August 1, 2000 to October 31, 2000. Holdings received 1,754 shares of Preferred Stock on March 30, 2001, which are convertible into 28,064 shares of common stock of the Company, in exchange for the delayed payment of the dividend described above. ITEM 7. MATERIALS TO BE FILED AS EXHIBITS. Exhibit 1: Powers of Attorney for the Reporting Persons (filed herewith). Page 7 of 14 Pages SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct, and agrees that this Statement may be filed collectively on behalf of each of the undersigned by Explorer Holdings, L.P., Explorer Holdings GenPar, LLC, Hampstead Investment Partners III, L.P., Donald J. McNamara and Daniel A. Decker. Date: April 10, 2001 EXPLORER HOLDINGS, L.P. By: Explorer Holdings GenPar, LLC, its General Partner By: /s/ Daniel A. Decker --------------------------- Daniel A. Decker Managing Member EXPLORER HOLDINGS GENPAR, LLC By: /s/ William T. Cavanaugh, Jr. --------------------------------- William T. Cavanaugh, Jr. Authorized Officer HAMPSTEAD INVESTMENT PARTNERS III, L.P. By: Hampstead Investment Partners III GenPar, L.P., its General Partner By: Hampstead GenPar III, LLC, its General Partner By: /s/ William T. Cavanaugh, Jr. ------------------------------- William T. Cavanaugh, Jr. Authorized Officer /s/ Donald J. McNamara ----------------------------------- Donald J. McNamara /s/ Daniel A. Decker ----------------------------------- Daniel A. Decker Page 8 of 14 Pages EXHIBIT INDEX Exhibit 1: Powers of Attorney for the Reporting Persons (filed herewith). Page 9 of 14 Pages POWER OF ATTORNEY Statements on Schedule 13D Explorer Holdings, L.P. (the "Company") hereby constitutes and appoints William T. Cavanaugh, Jr., Daniel A. Decker and Donald J. McNamara, and each of them, as the Company's true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, to sign on the Company's behalf any or all Statements on Schedule 13D, and any or all amendments thereto, relating to the capital stock of Omega Healthcare Investors, Inc. and to file the same, with all exhibits thereto, with the Securities and Exchange Commission, granting unto said attorneys-in fact or agents and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the promises, hereby ratifying and confirming all that said attorneys-in-fact or agents, or any of them or their substitutes, may lawfully do or cause to be done by virtue hereof. EXPLORER HOLDINGS, L.P. By: Explorer Holdings GenPar, LLC, Its General Partner By: /s/ Daniel A. Decker -------------------------------- Daniel A. Decker Managing Member Page 10 of 14 Pages POWER OF ATTORNEY Statements on Schedule 13D Explorer Holdings GenPar, LLC (the "Company") hereby constitutes and appoints William T. Cavanaugh, Jr., Daniel A. Decker and Donald J. McNamara, and each of them, as the Company's true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, to sign on the Company's behalf any or all Statements on Schedule 13D, and any or all amendments thereto, relating to the capital stock of Omega Healthcare Investors, Inc. and to file the same, with all exhibits thereto, with the Securities and Exchange Commission, granting unto said attorneys-in-fact or agents and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the promises, hereby ratifying and confirming all that said attorneys-in-fact or agents, or any of them or their substitutes, may lawfully do or cause to be done by virtue hereof. EXPLORER HOLDINGS GENPAR, LLC By: /s/ William T. Cavanaugh, Jr. --------------------------------- William T. Cavanaugh, Jr. Authorized Officer Page 11 of 14 Pages POWER OF ATTORNEY Statements on Schedule 13D Hampstead Investment Partners III, L.P. (the "Company") hereby constitutes and appoints William T. Cavanaugh, Jr., Daniel A. Decker and Donald J. McNamara, and each of them, as the Company's true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, to sign on the Company's behalf any or all Statements on Schedule 13D, and any or all amendments thereto, relating to the capital stock of Omega Healthcare Investors, Inc. and to file the same, with all exhibits thereto, with the Securities and Exchange Commission, granting unto said attorneys-in-fact or agents and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the promises, hereby ratifying and confirming all that said attorneys-in-fact or agents, or any of them or their substitutes, may lawfully do or cause to be done by virtue hereof. HAMPSTEAD INVESTMENT PARTNERS III, L.P. By: Hampstead Investment Partners III GenPar, L.P., Its General Partner By: Hampstead GenPar III, LLC, its General Partner By: /s/ William T. Cavanaugh, Jr. ------------------------------------- William T. Cavanaugh, Jr. Authorized Officer Page 12 of 14 Pages POWER OF ATTORNEY Statements on Schedule 13D The undersigned hereby constitutes and appoints William T. Cavanaugh, Jr. and Daniel A. Decker, and each of them, as the undersigned's true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, to sign on the undersigned's behalf any or all Statements on Schedule 13D, and any or all amendments thereto, relating to the capital stock of Omega Healthcare Investors, Inc., and to file the same, with all exhibits thereto, with the Securities and Exchange Commission, granting unto said attorneys-in-fact or agents and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the promises, hereby ratifying and confirming all that said attorneys-in-fact or agents, or any of them or their substitutes, may lawfully do or cause to be done by virtue hereof. /s/ Donald J. McNamara -------------------------- Donald J. McNamara Page 13 of 14 Pages POWER OF ATTORNEY Statements on Schedule 13D The undersigned hereby constitutes and appoints William T. Cavanaugh, Jr. and Donald J. McNamara, and each of them, as the undersigned's true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, to sign on the undersigned's behalf any or all Statements on Schedule 13D, and any or all amendments thereto, relating to the capital stock of Omega Healthcare Investors, Inc., and to file the same, with all exhibits thereto, with the Securities and Exchange Commission, granting unto said attorneys-in-fact or agents and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the promises, hereby ratifying and confirming all that said attorneys-in-fact or agents, or any of them or their substitutes, may lawfully do or cause to be done by virtue hereof. /s/ Daniel A. Decker -------------------------- Daniel A. Decker Page 14 of 14 Pages -----END PRIVACY-ENHANCED MESSAGE-----